Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.
about
Melanoma-restricted genesRetinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaA systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells.Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucoseExpression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.SPARC: a matricellular regulator of tumorigenesis.Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arraysIdentification and characterization of the novel reversible and selective cathepsin X inhibitors.Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma.[Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer].
P2860
Q24793788-11FC7B7E-2EBE-4D64-9DE9-366746717B07Q30986201-DB99E289-7054-4DB1-8120-057724BBE3B6Q33289965-D045AC6E-CDEA-40D1-BA27-EC232F6E3568Q33612332-9AC8DC8F-C2A4-4592-99CB-97BA62B3C8F3Q34037880-2CDC607B-6A2B-4806-A37C-F6B76971909DQ34762291-860C87C0-CDEF-4925-B5C2-68AAEBD8E079Q35234272-58CF6B98-C60B-446B-B159-39A177F8CC51Q36126666-3F460C78-7200-4DC8-84F5-7FCC6E7B7D23Q36322404-864A807F-F84C-4AE8-B84B-47A3DDEB07F7Q37267107-51632A15-4E23-42EB-B410-58122942319DQ37353781-C54C9513-C20F-4395-A85F-3617345A4915Q37610020-90031FDA-9901-46A7-B57B-FA3DE94F3D78Q38199932-A3298FFE-5895-4C09-AE6B-8CAFFF74D5D3Q40420929-B16E5391-A1A7-43F2-86C0-012FE9B4B441Q41126114-39759011-2858-46E2-88E9-A0AD2220F3BEQ44044551-94234F0F-BA51-44FF-B2EB-EB39BC79755EQ45122606-0B968781-96C5-48CD-A75B-62DAB260E450Q55465512-4DE69A28-3430-4447-B37D-3BF457EF5FB1
P2860
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Identification of differential ...... cterize aggressive phenotypes.
@en
type
label
Identification of differential ...... cterize aggressive phenotypes.
@en
prefLabel
Identification of differential ...... cterize aggressive phenotypes.
@en
P2093
P2860
P1476
Identification of differential ...... cterize aggressive phenotypes.
@en
P2093
Landthaler M
P2860
P304
P356
10.1111/J.0906-6705.2003.00082.X
P577
2003-12-01T00:00:00Z